Inhibition of HIV type 1 infection with a RANTES-IgG3 fusion protein.

Challita-Eid, P M; Klimatcheva, E; Day, B T; Evans, T; Dreyer, K; Rimel, B J; Rosenblatt, J D; Planelles, V

Challita-Eid, P M; Klimatcheva, E; Day, B T; Evans, T; Dreyer, K; Rimel, B J; Rosenblatt, J D; Planelles, V.

Affiliation

Challita-Eid PM; Department of Medicine, University of Rochester Cancer Center, New York 14642, USA.

AIDS Res Hum Retroviruses ; 14(18): 1617-24, 1998 Dec 20.

Article in En | MEDLINE | ID: mdl-9870314

Subject(s)

Chemokine CCL5/immunology; HIV-1/immunology; Immunoglobulin G/immunology; Recombinant Fusion Proteins/immunology; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; HIV-1/physiology; Humans; Membrane Fusion/immunology; Neutralization Tests; Receptors, CXCR4/metabolism; Recombinant Fusion Proteins/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Immunoglobulin G / HIV-1 / Chemokine CCL5 Limits: Humans Language: En Journal: AIDS Res Hum Retroviruses Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 1998 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links